Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1106-1115

  Cesano, Alessandra ^a   Visonneau, Sophie ^a   Deaglio, Silvia ^b   Malavasi, Fabio ^b,c   Santoli, Daniela ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD38 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOTOXIN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CALCIUM MOBILIZATION; CELL ADHESION; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; EXOCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADP-RIBOSYL CYCLASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; CALCIUM; CELL DEGRANULATION; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTRACELLULAR FLUID; KILLER CELLS, LYMPHOKINE-ACTIVATED; LIGANDS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; NAD+ NUCLEOSIDASE; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031914417     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Malavasi, F., A. Funaro, S. Roggero, A. Horensyein, L. Calosso and K. Metha. 1994. Human CD38: a glycoprotein in search of a function. Immunol. Today 15:95.
2. Jackson, D., and J. Bell. 1990. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with unusual discontinuous pattern of expression during lymphocyte differentiation. J. Immunol. 144:2811.
3. Lund, F., N. Solvason, J. C. Grimaldi, R. M. Parkhouse, and M. Howard. 1995. Murine CD38: an immunoregulatory ectoenzyme. Immunol. Today 16:469.
4. Ramaschi, G., M. Torti, E. T. Festetics, F. Sinigaglia, F. Malavasi, F., and C. Balduini. 1996. Expression of cyclic ADP-ribose-synthetizing CD38 molecule on human platelet membrane. Blood 87:2308.
5. Funaro, A., G. C. Spagnoli, C. M. Ausiello, M. Alessio, S. Roggero, D. Delia, M. Zaccolo, and F. Malavasi. 1990. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol. 145:2390.
6. Zupo, S., E. Rugarli, M. Dono, G. Tamborelli, F. Malavasi, and M. Ferrarini. 1994. CD38 signaling by agonistic monoclonal antibodies prevents apoptosis of human germinal center B cells. Eur. J. Immunol. 24:1218.
7. Funaro, A. L. B. De Monte, U. Dianzani, M. Forni, and F. Malavasi. 1993. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur. J. Immunol. 23:2407.
8. Kumagai, M., E. Coustan-Smith, D. J. Murry, O. Silvennoinen, G. P. Murti, D. J. Evans, F. Malavasi, and D. Campana. 1995. Ligation of CD38 suppresses human B lymphopoiesis. J. Exp. Med. 181:1101.
9. + lymphocytes: role of human CD38 molecule. J. Immunol. 153:952.
10. Howard, M., J. C. Grimaldi, F. J. Baxer, F. E. Lund, L. Santos-Argumedo, R. M. E. Parkhouse, and T. F. Walseth. 1993. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 262:1056.
11. +-glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities in human red cells. Biochem. Biophys. Res. Commun. 196:1459.
12. + converting enzymes: extensive structural homology with the genes for murine BST-1 and aplysian ADP-ribosyl cyclase. J. Immunol. 159:3858.
13. 2+ mobilizing activity. J. Biol. Chem. 264:1608.
14. + into a calcium-mobilizing metabolite. Cell Regul. 2:203.
15. 2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science 253:1143.
16. Deaglio, S., M. Morra, R. Mallone, C. M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi. 1998. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. In press.
17. Ausiello, C. M., A. La Sala, C. Ramoni, F. Urbani, A. Funaro, and F. Malavasi. 1996. Secretion of IFN-γ, IL-6, granulocyte-macrophage colony-stimulating factor and 1L-10 cytokines after activation of human purified T lymphocytes upon CD38 ligation. Cell. Immunol. 173:192.
18. Deaglio, S., U. Dianzani, A. L. Horenstein, J. E. Fernandez, C. van Kooten, M. Bragardo, A. Funaro, G. Garbarino, F. Di Virgilio, J. Banchereau, and F. Malavasi. 1996. Human CD38 ligand: a 120-kDa protein predominantly expressed on endothelial cells. J. Immunol. 156:727.
19. Cesano, A., and D. Santoli. 1992. Two unique human leukemic T-cell lines endowed with a stable cytotoxic function and a different spectrum of target reactivity analysis and modulation of their lytic mechanisms. In Vitro Cell. Dev. Biol. 28:A648.
20. Cesano, A., and D. Santoli. 1992. Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-α and interferon-γ in two human cytotoxic leukemic T-cell lines. In Vitro Cell. Dev. Biol. 28:A657.
21. Cesano, A., S. Visonneau, S. C. Clark, and D. Santoli. 1996. Cellular and molecular mechanisms of activation of MHC non-restricted cytotoxic cells by IL-12. J. Immunol. 151:2943.
22. Francia de Celle, P., S. Mariani, L. Riera, A. Stacchini, O. Reato, and R. Foa. 1996. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87:4382.
23. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
24. Takayama, H., G. Trenn, and M. V. Sitkovsky. 1987. A novel cytotoxic T lymphocyte activation assay: optimized conditions for antigen receptor-triggered granule enzymatic secretion. J. Immunol. Methods 104:183.
25. Cesano, A., S. Visonneau, K. A. Jeglum, J. Owen, K. Wilkinson, K. Carner, L. Reese, and D. Santoli. 1996. Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumors. Cancer Res. 56:3021.
26. Lopez, M., D. Olive, and P. Mannoni. 1989. Analysis of cytosolic ionized calcium variation in polymorphonuclear leukocytes using flow cytometry and indo-1 AM. Cytometry 10:165:173.
27. Cesano, A., R. O'Connor, B. Lange, J. Finan, G. Rovera, and D. Santoli. 1991. Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 77:2463.
28. Paige, C. J., P. W. Kincade, and P. Ralph. 1978. Murine B cell leukemia line with inducible surface immunoglobulin expression. J. Immunol. 121:641.
29. Mehta, K., S. Umar, and F. Malavasi. 1996. Human CD38, a cell surface molecule with multiple functions. FASEB J. 10:1408-1417.
30. Kramer, G., G. Steiner, D. Fodinger, E. Fiebiger, C. Rappersberger, S. Binder, J. Hofbaver, and M. Marberger. 1995. High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease. J. Urol. 154:1636.
31. Lund, F. E., Y. Naixuan, K. Kwang-Myong, M. Reth, and M. Howard. 1996. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J. Immunol. 157:1455.
32. Cesano, A., S. Visonneau, S. Pasquini, G. Rovera, and D. Santoli. 1996. Antitumor efficacy of a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in immunocompetent mice bearing syngeneic leukemia. Cancer Res. 56:444.
33. O'Connor, R., A. Cesano, B. Lange, J. Finan, P. C. Nowell, S. C. Clark, S. C. Raimondi, G. Rovera, and D. Santoli. 1991. Growth factor requirements of childhood acute T lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro. Blood 77:1534.
34. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, A. O'Rourke, A. Sherchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (FAS/APO-1) death-inducing signaling complex. Cell 85:817.